MMP-9 Upregulation May Predict Hemorrhagic Transformation After Endovascular Thrombectomy

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 May 27

PMID 38798706

Authors

Jin-An Huang

Yu-Hsuan Wu

Po-Lin Chen

Yi-Chinn Weng

I-Chen Chiang

Yu-Ting Huang

Wen-Hai Chou

Affiliations

Soon will be listed here.

Abstract

Background: Hemorrhagic transformation (HT) is a serious complication after endovascular thrombectomy (EVT) for patients with acute ischemic stroke (AIS). We analyzed the plasma levels of MMP-9 before and after EVT and assessed the temporal changes of MMP-9 that may be associated with, and therefore predict, HT after EVT.

Methods: We enrolled 30 AIS patients who received EVT, and 16 (53.3%) developed HT. The levels of MMP-9 in plasma collected from the arteries of AIS patients before and immediately after EVT were measured using ELISA. The percent change in MMP-9 after EVT (after/before) was calculated and compared between patients with and without HT.

Results: The median age of the AIS patients was 70 years, and 13 patients (43.3%) were men. The median National Institutes of Health Stroke Scale (NIHSS) scores of patients with HT were 18 on admission and 18 after EVT. The median NIHSS scores of patients without HT were 17 on admission and 11 after EVT. Patients with HT demonstrated significantly greater percentage increases in arterial MMP-9 levels after EVT.

Conclusion: Patients with AIS who developed HT had significantly increased arterial MMP-9 levels after EVT, suggesting that the upregulation of MMP-9 following EVT could serve as a predictive biomarker for HT.

References

Ji Y, Gao Q, Ma Y, Wang F, Tan X, Song D . An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity. Pharmacol Res. 2023; 190:106720. DOI: 10.1016/j.phrs.2023.106720. View

Bourcier R, Saleme S, Labreuche J, Mazighi M, Fahed R, Blanc R . More than three passes of stent retriever is an independent predictor of parenchymal hematoma in acute ischemic stroke. J Neurointerv Surg. 2018; 11(7):625-629. DOI: 10.1136/neurintsurg-2018-014380. View

Li Y, Zhong W, Jiang Z, Tang X . New progress in the approaches for blood-brain barrier protection in acute ischemic stroke. Brain Res Bull. 2018; 144:46-57. DOI: 10.1016/j.brainresbull.2018.11.006. View

Mannello F . Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness.... Arterioscler Thromb Vasc Biol. 2008; 28(4):611-4. DOI: 10.1161/ATVBAHA.107.159608. View

Pikija S, Sztriha L, Killer-Oberpfalzer M, Weymayr F, Hecker C, Ramesmayer C . Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke. J Neuroinflammation. 2018; 15(1):319. PMC: 6237008. DOI: 10.1186/s12974-018-1359-2. View

Trentini A, Manfrinato M, Castellazzi M, Bellini T . Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases. J Pers Med. 2022; 12(8). PMC: 9331234. DOI: 10.3390/jpm12081196. View

Goetz L, Schork N . Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018; 109(6):952-963. PMC: 6366451. DOI: 10.1016/j.fertnstert.2018.05.006. View

Simpkins A, Janowski M, Oz H, Roberts J, Bix G, Dore S . Biomarker Application for Precision Medicine in Stroke. Transl Stroke Res. 2019; 11(4):615-627. PMC: 7299765. DOI: 10.1007/s12975-019-00762-3. View

Teng D, Pannell J, Rennert R, Li J, Li Y, Wong V . Endothelial trauma from mechanical thrombectomy in acute stroke: in vitro live-cell platform with animal validation. Stroke. 2015; 46(4):1099-106. DOI: 10.1161/STROKEAHA.114.007494. View

10.

Mizuma A, Yenari M . Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke. Front Neurol. 2017; 8:467. PMC: 5594066. DOI: 10.3389/fneur.2017.00467. View

11.

Adams Jr H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41. DOI: 10.1161/01.str.24.1.35. View

12.

Chaturvedi M, Kaczmarek L . Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol. 2013; 49(1):563-73. PMC: 3918117. DOI: 10.1007/s12035-013-8538-z. View

13.

von Kummer R, Broderick J, Campbell B, Demchuk A, Goyal M, Hill M . The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. Stroke. 2015; 46(10):2981-6. DOI: 10.1161/STROKEAHA.115.010049. View

14.

Del Zoppo G, Saver J, Jauch E, Adams Jr H . Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009; 40(8):2945-8. PMC: 2782817. DOI: 10.1161/STROKEAHA.109.192535. View

15.

Bhaskar S, Stanwell P, Cordato D, Attia J, Levi C . Reperfusion therapy in acute ischemic stroke: dawn of a new era?. BMC Neurol. 2018; 18(1):8. PMC: 5771207. DOI: 10.1186/s12883-017-1007-y. View

16.

Montellano F, Ungethum K, Ramiro L, Nacu A, Hellwig S, Fluri F . Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review. Stroke. 2021; 52(2):543-551. DOI: 10.1161/STROKEAHA.120.029232. View

17.

Campbell B, Donnan G, Lees K, Hacke W, Khatri P, Hill M . Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol. 2015; 14(8):846-854. DOI: 10.1016/S1474-4422(15)00140-4. View

18.

Rempe R, Hartz A, Bauer B . Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab. 2016; 36(9):1481-507. PMC: 5012524. DOI: 10.1177/0271678X16655551. View

19.

Mechtouff L, Bochaton T, Paccalet A, Crola Da Silva C, Buisson M, Amaz C . Matrix Metalloproteinase-9 Relationship With Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy. Front Neurol. 2020; 11:473. PMC: 7296118. DOI: 10.3389/fneur.2020.00473. View

20.

Saver J, Goyal M, van der Lugt A, Menon B, Majoie C, Dippel D . Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016; 316(12):1279-88. DOI: 10.1001/jama.2016.13647. View